FDA Investigator Antoinette L Ravelli
Antoinette L Ravelli has inspections in 3 countries as of 31 Oct 2023. Antoinette L Ravelli has collaborated with a combined 1449 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
144
Last Inspection Date:
31 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Poland,
China
Co-Investigator(s):
Abram Brown,
Albert M Brindle,
Amy L Singer,
Annemarie Bodnar,
Annet R Rajan,
Anthony M Criscuolo, Jr,
Brian L Szcyubialka,
Carol A Perry,
Carol A Robles,
Cary Greene,
Charlotte P Chang,
Craig W Swanson,
Daniel W Johnson,
David J Leray,
Debra D Devlieger,
Devon Jenkins,
Dhaval H Patel,
Doreen P Canetti,
Doreen P Gubbay,
Edward Oshaughnessy,
Eric Rothschild,
Eric S Myskowski,
Gillian B Nardelli,
Herrmann,
Jacqueline A O'shaughnessy, PhD,
Jennifer A Bazergui,
Jennifer Macmillan,
Jessica M Monteiro,
Jill M Sooter,
Jo Annc Declement,
Joseph R Hatcher,
Joseph T Dougherty,
Judith A Jones,
Judith A Paterson,
Judith Paterson,
Judith Peterson,
Justin A Boyd,
Justine Tomasso,
Karen A Spencer,
Karen E D'orazio,
Karen F Tomaziefski,
Keith A Schwartz,
Kelli F Dobilas,
Kelly I Anderson,
Kerry A Kurdilla,
King,
Kris K Moore,
Kristy A Zielny,
Krystyna M Kitson,
Laishan L Lam,
Lata C Mathew, PhD,
Lawrence R Johnson,
Marcelo O Mangalindan, Jr,
Margaret M Sands,
Mary F Bodick,
Meredith L Sheridan,
Michael A Taylor,
Michael Rosner,
Mielziner,
Nerizza B Guerin,
Paul L Bellamy,
Raicine M Campbell,
Randolph Campos Santiago,
Raymond L Cheung,
Regina T Brown,
Remache,
Robert W Calais,
Robert W Mccullough,
Robin P Mathew,
Ronald T Colucci,
Sarah K Graham,
Schultz,
Schwartz,
Seng Ching Hwang,
Sherri J Liu,
State Agency,
Stephanie T Durso,
Susan M Halsted,
Teigan M Mule,
Tressa T Lewis,
Valerie C Reed,
Wayne J Meyer,
William J Muszynski,
William W Dotts
Antoinette L Ravelli's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2004 | FDA 483 | Moyer Mitchell Co. - Form 483, 2004-12-27 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more